Physicians Practice May 7, 2024
Exploring liability risks related to medications like Ozempic and presenting an action plan for physicians to protect themselves against malpractice litigation.
A considerable rise in the public demand for weight loss drugs such as Ozempic and Wegovy has created a supply shortage, prompting many physicians to prescribe generic compounded semaglutide, which contains the active ingredient found in the brand-name versions. These non-FDA-approved alternatives are not covered by medical malpractice insurance and pose a great liability risk for the prescribers.
As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we will explore liability risks related to glucagon-like peptide-1 (GLP-1) medications like...
Today's Sponsors
Today's Sponsor